Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
MUSE
1 other identifier
observational
301
1 country
1
Brief Summary
The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 16, 2015
CompletedFirst Posted
Study publicly available on registry
December 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedResults Posted
Study results publicly available
May 28, 2021
CompletedMay 28, 2021
May 1, 2021
7 months
December 16, 2015
February 15, 2018
May 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Satisfaction Among Patients to Whom Mirvaso®/OnrelteaTM is Prescribed Question
Week 4
Study Arms (1)
Mirvaso® / Onreltea TM
Interventions
Eligibility Criteria
patient with persistent facial erythema of rosacea
You may qualify if:
- Patients to whom the physician has already decided to prescribe Mirvaso® /OnrelteaTM according to package insert
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Galderma R&Dlead
- Chiltern International Inc.collaborator
Study Sites (1)
Investigator site 1
Hamilton, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Stéphanie Leclerc
- Organization
- Galderma
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2015
First Posted
December 22, 2015
Study Start
October 1, 2015
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
May 28, 2021
Results First Posted
May 28, 2021
Record last verified: 2021-05